SMTL ID : 8rd9.1

human TRPM4 in SMA NBA

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

homo-tetramer

Ligands

4 x 01: 4-chloranyl-2-(2-naphthalen-1-yloxyethanoylamino)benzoic acid

01.1: 6 residues within 4Å: Chain A: S.444, W.445, V.485, H.489, Y.638, R.645 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:V.485 Salt bridges: A:H.489, A:R.645 01.6: 6 residues within 4Å: Chain B: W.445, V.485, H.489, S.505, Q.642, R.645 4 PLIP interactions: 4 interactions with chain B Hydrophobic interactions: B:V.485 Hydrogen bonds: B:Q.642, B:R.645 Salt bridges: B:H.489 01.7: 5 residues within 4Å: Chain C: S.444, W.445, V.485, H.489, Y.638 4 PLIP interactions: 4 interactions with chain C Hydrophobic interactions: C:V.485 Hydrogen bonds: C:Y.638, C:Y.638 Salt bridges: C:H.489 01.11: 4 residues within 4Å: Chain D: W.445, V.485, H.489, Y.638 5 PLIP interactions: 5 interactions with chain D Hydrophobic interactions: D:V.485 Hydrogen bonds: D:H.489, D:Y.638, D:Y.638 Salt bridges: D:H.489

8 x CLR: CHOLESTEROL(Non-covalent)(Covalent)

CLR.2: 11 residues within 4Å: Chain A: W.599, V.602, V.606 Chain B: L.518, L.522, P.541, L.544, R.545, F.548, Y.549, Y.552 7 PLIP interactions: 5 interactions with chain B, 2 interactions with chain A Hydrophobic interactions: B:L.522, B:P.541, B:L.544, B:F.548, B:Y.549, A:W.599, A:V.602 CLR.3: 14 residues within 4Å: Chain A: V.523, V.527, F.540, I.543, L.544, F.548 Chain B: L.372, L.375, L.376, S.379, R.380, L.383, V.384, F.480 8 PLIP interactions: 4 interactions with chain B, 4 interactions with chain A Hydrophobic interactions: B:L.375, B:L.375, B:L.376, B:L.383, A:V.523, A:F.540, A:F.540, A:I.543 CLR.4: 14 residues within 4Å: Chain A: L.515, L.518, G.519, L.522, P.541, L.544, R.545, F.548, Y.549, Y.552 Chain C: W.599, V.602, L.603, V.606 5 PLIP interactions: 3 interactions with chain C, 2 interactions with chain A Hydrophobic interactions: C:W.599, C:V.606, C:V.606, A:Y.549, A:Y.549 CLR.5: 15 residues within 4Å: Chain A: L.372, L.375, L.376, S.379, R.380, L.383, V.384, F.480 Chain C: V.523, V.527, F.540, I.543, L.544, V.547, F.548 8 PLIP interactions: 3 interactions with chain C, 5 interactions with chain A Hydrophobic interactions: C:V.523, C:V.527, C:F.540, A:L.375, A:L.376, A:L.376, A:R.380, A:V.384 CLR.8: 14 residues within 4Å: Chain C: L.372, L.375, L.376, S.379, R.380, L.383, V.384, F.480 Chain D: V.523, V.527, F.540, I.543, L.544, F.548 11 PLIP interactions: 5 interactions with chain C, 6 interactions with chain D Hydrophobic interactions: C:L.375, C:L.376, C:R.380, C:L.383, C:V.384, D:V.523, D:V.527, D:F.540, D:F.540, D:I.543, D:L.544 CLR.9: 16 residues within 4Å: Chain B: V.523, V.527, E.530, S.538, F.540, I.543, L.544, V.547, F.548 Chain D: L.372, L.375, L.376, S.379, R.380, L.383, V.384 12 PLIP interactions: 8 interactions with chain B, 4 interactions with chain D Hydrophobic interactions: B:V.523, B:V.523, B:V.527, B:F.540, B:F.540, B:I.543, B:I.543, D:L.372, D:L.375, D:L.383, D:V.384 Hydrogen bonds: B:S.538 CLR.10: 9 residues within 4Å: Chain B: W.599, V.602, V.606 Chain D: L.522, P.541, R.545, F.548, Y.549, Y.552 5 PLIP interactions: 3 interactions with chain D, 2 interactions with chain B Hydrophobic interactions: D:L.522, D:Y.549, D:Y.552, B:W.599, B:V.602 CLR.12: 11 residues within 4Å: Chain C: L.518, L.522, P.541, L.544, R.545, F.548, Y.549, Y.552 Chain D: W.599, V.602, V.606 6 PLIP interactions: 4 interactions with chain C, 2 interactions with chain D Hydrophobic interactions: C:L.518, C:L.522, C:L.544, C:Y.549, D:W.599, D:V.602

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ekundayo, B. et al., Identification of a Binding Site for Small Molecule Inhibitors Targeting Human. To Be Published

Release Date

2024-12-18

Peptides

Transient receptor potential cation channel subfamily M member 4: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
E

C
C

D
D

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Transient receptor potential cation channel subfamily M member 4